Last Updated: August 30, 2026

NEOMYCIN SULFATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Neomycin Sulfate, and what generic alternatives are available?

Neomycin Sulfate is a drug marketed by Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Pharmobedient, Roxane, Sandoz, Solaris Pharma Corp, Teva, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm. and is included in twenty NDAs.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are five drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NEOMYCIN SULFATE?
What are the global sales for NEOMYCIN SULFATE?
What is Average Wholesale Price for NEOMYCIN SULFATE?

Summary for NEOMYCIN SULFATE

US Patents:	0
Applicants:	14
NDAs:	20
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	12
Patent Applications:	643
DailyMed Link:	NEOMYCIN SULFATE at DailyMed

Drug patent expirations by year for NEOMYCIN SULFATE

Recent Clinical Trials for NEOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Universitt Luzern	PHASE4
Vietstar Biomedical Research	N/A
Huro Biotech Joint Stock Company	N/A

See all NEOMYCIN SULFATE clinical trials

Pharmacology for NEOMYCIN SULFATE

Drug Class	Aminoglycoside Antibacterial

Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE

Anti-Bacterial Agents
Protein Synthesis Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE

A01AB	Antiinfectives and antiseptics for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

A07AA	Antibiotics
A07A	INTESTINAL ANTIINFECTIVES
A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A	Alimentary tract and metabolism

B05CA	Antiinfectives
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

D06AX	Other antibiotics for topical use
D06A	ANTIBIOTICS FOR TOPICAL USE
D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D	Dermatologicals

J01GB	Other aminoglycosides
J01G	AMINOGLYCOSIDE ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

R02AB	Antibiotics
R02A	THROAT PREPARATIONS
R02	THROAT PREPARATIONS
R	Respiratory system

S01AA	Antibiotics
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

S02AA	Antiinfectives
S02A	ANTIINFECTIVES
S02	OTOLOGICALS
S	Sensory organs

S03AA	Antiinfectives
S03A	ANTIINFECTIVES
S03	OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S	Sensory organs

US Patents and Regulatory Information for NEOMYCIN SULFATE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bristol Myers Squibb	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060365-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fougera	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	OINTMENT;TOPICAL	062608-001	May 23, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sandoz	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	061586-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Lilly	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060385-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alcon Pharms Ltd	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate; neomycin sulfate	SOLUTION/DROPS;OPHTHALMIC	062714-001	Jul 21, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.